Clinical and endoscopic remission in the Lactobacillus GG (LGG) and placebo groups
| LGG (n=23) | Placebo (n=22) | p Value | |
|---|---|---|---|
| *Crohn's disease activity index ≤150 after 52 weeks of therapy. | |||
| †Rutgeerts score: 0–1=remission; 2–4=recurrence. | |||
| There were no statistically significant differences. | |||
| Non-compliance (%) | 2 (8.7) | 1 (4.5) | 0.968 |
| Protocol violation (%) | 3 (13.0) | 2 (9.0) | 1.000 |
| Clinical remission* (%) | 15 (83.3) | 17 (89.4) | 0.948 |
| Endoscopic remission† (%) | 6 (40.0) | 11 (64.7) | 0.243 |
| Score 0 | 1 | 9 | |
| 1 | 5 | 2 | |
| Endoscopic recurrence† (%) | 9 (60.0) | 6 (35.3) | 0.297 |
| Score 2 | 3 | 3 | |
| 3 | 2 | 0 | |
| 4 | 4 | 3 | |